Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 14,269 | 11,772 | 7,410 | 316,192 | 17,193 |
| Gross Profit | 14,269 | 11,772 | 7,410 | 316,192 | 17,193 |
| Operating Expenses | 120,773 | 116,667 | 111,542 | 183,334 | 125,460 |
| Operating Income | -106,504 | -104,895 | -104,132 | 132,858 | -108,267 |
| Other Income | 9,836 | 13,883 | 5,463 | 11,305 | 12,179 |
| Pre-tax Income | -96,668 | -91,012 | -98,669 | 144,163 | -96,088 |
| Income Tax | N/A | 39 | N/A | N/A | N/A |
| Net Income Continuous | -96,668 | -91,051 | -98,669 | 142,797 | -96,088 |
| Net Income | $-96,668 | $-91,051 | $-98,669 | $142,797 | $-96,088 |
| EPS Basic Total Ops | -1.17 | -1.11 | -1.21 | 1.91 | -1.22 |
| EPS Basic Continuous Ops | -1.17 | -1.11 | -1.21 | 1.92 | -1.22 |
| EPS Diluted Total Ops | -1.17 | -1.11 | -1.21 | 1.91 | -1.22 |
| EPS Diluted Continuous Ops | -1.17 | -1.11 | -1.21 | 1.92 | -1.22 |
| EPS Diluted Before Non-Recurring Items | -1.17 | -1.11 | -1.21 | 1.73 | -1.22 |
| EBITDA(a) | $-106,652 | $-105,245 | $-105,277 | $130,866 | $-110,964 |